Based on the bid received for Paytm's Rs 18,300 crore initial public offer (IPO), the company will list an enterprise valuation of Rs 1,49,428 crore or slightly over USD 20 billion at an exchange rate of 74.35.
Qualified institutional buyers (QIBs), who were less than enthusiastic in participating in the IPO in the initial two days, flooded the issue, seeking 1.59 times the shares reserved for them.
The initial public offering of Paytm's parent company One97 Communications Ltd received bids for 2.34 crore equity shares against the offer size of 4.83 crore shares, according to information available from stock exchanges.
The initial public offering of Paytm's parent company, One97 Communications Ltd received bids for 88.23 lakh equity shares against the offer size of 4.83 crore shares, according to information available from stock exchanges.
Paytm plans to raise Rs 18,300 crore from the IPO which comprises Rs 8,300 crore from issuance of fresh equity and Rs 10,000 crore from offer for sale (OFS).
According to the documents, Paytm's merchant base grew to 2.11 crore as of March 31, 2021, from 1.12 crore in March 2019.
The airline plans to garner up to Rs 3,600 crore through sale of shares, according to the Draft Red Herring Prospectus (DRHP).
The IPO is entirely an offer for sale of 35,688,064 equity shares by the promoter Dr S Surendranath Reddy and investors -- Karakoram Ltd and Kedaara Capital Alternative Investment Fund-Kedaara Capital AIF I.
VLCC Health Care Ltd has filed preliminary papers with markets regulator Sebi to raise funds through an initial share sale.
As a part of the OFS, QSR Management Trust will sell 8.50 lakh shares, Sapphire Foods Mauritius Ltd will offload 55.69 lakh shares, WWD Ruby Ltd will divest 48.46 lakh shares and Amethyst will offer 39.62 lakh shares.
Devyani International IPO Allotment: The ₹1,838-crore IPO received bids for 13,13,77,91,700 shares against 11,25,69,719 shares on offer, according to an update on the NSE.
Krsnaa Diagnostics IPO Allotment Date, Krsnaa Diagnostics IPO GMP: Krsnaa IPO subscription status will be declared on August 11.
This comes after four companies -- Devyani International, Krsnaa Diagnostics, Windlas Biotech and Exxaro Tiles-- launched their initial share-sales last week to mobilize Rs 3,614 crore.
The initial share-sale will be open for public subscription on Aug 10, and conclude on Aug 12, the company said.
The 3-day initial share-sale will open for public subscription on Aug 9 and conclude on Aug 11, the company announced.
Chemplast Sanmar Ltd on Thursday said it has fixed a price band of Rs 530-541 a share for its Rs 3,850-crore initial public offering.
The initial public offering of up to 1,342,4000 equity shares comprises a fresh issue of up to 1,11,86,000 equity shares and an offer-for-sale of up to 22,38,000 equity shares by Dixitkumar Patel.
As a part of OFS, Phi Capital will sell 16 lakh equity shares, Kitara will offload 33,40,713 equity shares, Somerset Indus Healthcare Fund I Ltd will offer 35,63,427 equity shares and Lotus Management Solutions will sell 21,380 equity shares.
The IPO comprises fresh issuance of equity shares worth Rs 165 crore and and an offer for sale of up to 5,142,067 equity shares.
In addition, 13 domestic investors including 6 mutual funds, 6 life insurance companies and one general insurance company participated in the anchor book too.
Top News
Latest News
